SCHEMBL2197464

SCHEMBL2197464

COC(=O)c1ccc(C)c(C(=O)c2ccc(Nc3cc(F)cc(F)c3)cc2Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.51
MAPK12 P53778 10/20 0.51
MAPK11 Q15759 10/20 0.51
MAPK14 Q16539 10/20 0.51
MAPT P10636 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
CASP3 P42574 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
CSNK2A1 P68400 1/20 0.41
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200820 0.92 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199501 0.91 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2195134 0.86 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199405 0.86 MAPK14 (0.61) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199428 0.85 MAPK14 (0.60) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199858 0.83 MAPK14 (0.52) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199475 0.82 MAPK14 (0.47) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2198749 0.82 MAPK14 (0.54) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL1908350 0.81 MAPK14 (0.76) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL27634454 0.81 MAPK13 (0.60) MAPK13MAPK12MAPK11MAPK14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.